Ensysce Biosciences (ENSC) Current Leases (2020 - 2023)

Ensysce Biosciences (ENSC) has reported Current Leases for 4 consecutive years, with $2732.0 the latest figure, recorded in Q3 2023.

• On a quarterly basis, Current Leases fell 92.28% year-over-year to $2732.0 in Q3 2023; TTM through Sep 2023 was $2732.0, a 92.28% decrease from a year earlier, with the FY2022 full-year figure at $27315.0, up 9.81% from the prior year.
• Current Leases was $2732.0 for Q3 2023 at Ensysce Biosciences, down from $10926.0 in the prior quarter.
• Over five years, Current Leases peaked at $35403.0 in Q3 2022 and troughed at $2732.0 in Q3 2023.
• A 4-year average of $19615.1 and a median of $19120.0 in 2023 frame the typical range for Current Leases.
• Across the five-year window, Current Leases rose 11.8% in 2022 and sank 92.28% in 2023, its largest moves.
• Over 4 years, Current Leases stood at $25500.0 in 2020, then dropped by 2.45% to $24874.0 in 2021, then grew by 9.81% to $27315.0 in 2022, then slumped by 90.0% to $2732.0 in 2023.
• The last three Current Leases figures came in at $2732.0 (Q3 2023), $10926.0 (Q2 2023), and $19120.0 (Q1 2023), per Business Quant data.